Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
29 04 2022
Historique:
received: 20 07 2021
revised: 04 09 2021
accepted: 09 09 2021
pubmed: 1 4 2022
medline: 3 5 2022
entrez: 31 3 2022
Statut: ppublish

Résumé

Focal malformations of cortical development including focal cortical dysplasia, hemimegalencephaly and megalencephaly, are a spectrum of neurodevelopmental disorders associated with brain overgrowth, cellular and architectural dysplasia, intractable epilepsy, autism and intellectual disability. Importantly, focal cortical dysplasia is the most common cause of focal intractable paediatric epilepsy. Gain and loss of function variants in the PI3K-AKT-MTOR pathway have been identified in this spectrum, with variable levels of mosaicism and tissue distribution. In this study, we performed deep molecular profiling of common PI3K-AKT-MTOR pathway variants in surgically resected tissues using droplet digital polymerase chain reaction (ddPCR), combined with analysis of key phenotype data. A total of 159 samples, including 124 brain tissue samples, were collected from 58 children with focal malformations of cortical development. We designed an ultra-sensitive and highly targeted molecular diagnostic panel using ddPCR for six mutational hotspots in three PI3K-AKT-MTOR pathway genes, namely PIK3CA (p.E542K, p.E545K, p.H1047R), AKT3 (p.E17K) and MTOR (p.S2215F, p.S2215Y). We quantified the level of mosaicism across all samples and correlated genotypes with key clinical, neuroimaging and histopathological data. Pathogenic variants were identified in 17 individuals, with an overall molecular solve rate of 29.31%. Variant allele fractions ranged from 0.14 to 22.67% across all mutation-positive samples. Our data show that pathogenic MTOR variants are mostly associated with focal cortical dysplasia, whereas pathogenic PIK3CA variants are more frequent in hemimegalencephaly. Further, the presence of one of these hotspot mutations correlated with earlier onset of epilepsy. However, levels of mosaicism did not correlate with the severity of the cortical malformation by neuroimaging or histopathology. Importantly, we could not identify these mutational hotspots in other types of surgically resected epileptic lesions (e.g. polymicrogyria or mesial temporal sclerosis) suggesting that PI3K-AKT-MTOR mutations are specifically causal in the focal cortical dysplasia-hemimegalencephaly spectrum. Finally, our data suggest that ultra-sensitive molecular profiling of the most common PI3K-AKT-MTOR mutations by targeted sequencing droplet digital polymerase chain reaction is an effective molecular approach for these disorders with a good diagnostic yield when paired with neuroimaging and histopathology.

Identifiants

pubmed: 35355055
pii: 6555860
doi: 10.1093/brain/awab376
pmc: PMC9630661
doi:

Substances chimiques

MTOR protein, human EC 2.7.1.1
Class I Phosphatidylinositol 3-Kinases EC 2.7.1.137
Proto-Oncogene Proteins c-akt EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

925-938

Subventions

Organisme : NICHD NIH HHS
ID : P50 HD103524
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS092772
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) (2022). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

J Virol Methods. 2017 Aug;246:15-20
pubmed: 28414163
JCI Insight. 2016 Jun 16;1(9):
pubmed: 27631024
Brain. 2006 Feb;129(Pt 2):352-65
pubmed: 16291806
Clin Chem. 2013 Nov;59(11):1670-2
pubmed: 24003063
Neuropathol Appl Neurobiol. 2018 Feb;44(1):6-17
pubmed: 29359340
Nat Genet. 2012 Jun 24;44(8):941-5
pubmed: 22729223
JCI Insight. 2019 Nov 1;4(21):
pubmed: 31536475
Epilepsia. 2011 Jan;52(1):158-74
pubmed: 21219302
Am J Med Genet C Semin Med Genet. 2019 Dec;181(4):582-590
pubmed: 31441589
Ann Neurol. 2015 Apr;77(4):720-5
pubmed: 25599672
Biol Blood Marrow Transplant. 2018 May;24(5):1069-1078
pubmed: 29305193
JAMA Neurol. 2016 Jul 1;73(7):836-845
pubmed: 27159400
Neurol Genet. 2020 Dec 08;7(1):e540
pubmed: 33542949
Am J Med Genet C Semin Med Genet. 2014 Jun;166C(2):156-72
pubmed: 24888963
Acta Neuropathol. 2019 Dec;138(6):885-900
pubmed: 31444548
Neuropathol Appl Neurobiol. 2018 Feb;44(1):18-31
pubmed: 29359399
Brain. 2017 Oct 1;140(10):2610-2622
pubmed: 28969385
Elife. 2015 Dec 03;4:
pubmed: 26633882
Sci Rep. 2018 May 2;8(1):6944
pubmed: 29720614
Trends Immunol. 2012 May;33(5):215-23
pubmed: 22365572
Am J Med Genet A. 2018 Nov;176(11):2301-2308
pubmed: 30063105
J Clin Invest. 2018 Jun 1;128(6):2452-2458
pubmed: 29708508
Eur J Med Genet. 2018 Dec;61(12):738-740
pubmed: 29883676
Int J Oral Sci. 2013 Sep;5(3):121-9
pubmed: 23887128
Am J Med Genet. 2002 Nov 1;112(4):315-7
pubmed: 12376930
Front Oncol. 2020 Nov 13;10:579327
pubmed: 33304846
Brain. 2015 Jun;138(Pt 6):1613-28
pubmed: 25722288
Neurology. 2014 Jun 10;82(23):2101-6
pubmed: 24814846
Neurosurg Focus. 2013 Jun;34(6):E8
pubmed: 23724842
J Mol Diagn. 2015 May;17(3):265-72
pubmed: 25769900
Brain. 2009 Aug;132(Pt 8):2079-90
pubmed: 19506069
Clin Chim Acta. 2021 Feb;513:17-24
pubmed: 33301768
Pract Lab Med. 2020 Feb 03;19:e00153
pubmed: 32123717
Epilepsy Res. 2015 May;112:137-49
pubmed: 25847349
Front Neurosci. 2021 Jan 22;14:580357
pubmed: 33551717
Nat Rev Neurol. 2020 Nov;16(11):618-635
pubmed: 32895508
J Pediatr. 2015 Apr;166(4):1048-54.e1-5
pubmed: 25681199
Pediatr Radiol. 1995;25(5):387-8
pubmed: 7567275
Epilepsia. 2021 Jun;62(6):1416-1428
pubmed: 33949696
Oncotarget. 2012 May;3(5):546-58
pubmed: 22643842
Annu Rev Pathol. 2017 Jan 24;12:547-571
pubmed: 28135561
J Mol Diagn. 2016 Nov;18(6):851-863
pubmed: 27637301
Nat Genet. 2012 Jun 24;44(8):934-40
pubmed: 22729224
Science. 2012 Dec 21;338(6114):1619-22
pubmed: 23160955
Int J Mol Med. 2020 Sep;46(3):957-964
pubmed: 32705153
Expert Rev Neurother. 2021 Nov;21(11):1213-1224
pubmed: 33834938
Appl Immunohistochem Mol Morphol. 2017 Aug;25(7):460-466
pubmed: 26808133
Methods Mol Biol. 2017;1492:95-106
pubmed: 27822858
Epilepsia. 2007;48 Suppl 2:21-32
pubmed: 17571350
Nat Biotechnol. 2003 Jun;21(6):673-8
pubmed: 12730666
Ann Diagn Pathol. 2020 Jun;46:151523
pubmed: 32325422
Sci Rep. 2016 Mar 09;6:22985
pubmed: 26957145

Auteurs

Filomena Pirozzi (F)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Matthew Berkseth (M)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Rylee Shear (R)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Lorenzo Gonzalez (L)

Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Andrew E Timms (AE)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Josef Sulc (J)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Emily Pao (E)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Nora Oyama (N)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Francesca Forzano (F)

Department of Clinical Genetics, Guy's and St Thomas NHS Foundation Trust and King's College London, London, UK.

Valerio Conti (V)

Pediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Children's Hospital A. Meyer-University of Florence, Italy.

Renzo Guerrini (R)

Pediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Children's Hospital A. Meyer-University of Florence, Italy.

Emily S Doherty (ES)

Section of Clinical Genetics, Carilion Clinic Children's Hospital, Roanoke, VA, USA.

Sulagna C Saitta (SC)

Division of Medical Genetics, Department of Obstetrics and Gynecology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA.

Christina M Lockwood (CM)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Brotman-Baty Institute for Precision Medicine, University of Minnesota, Seattle, WA, USA.

Colin C Pritchard (CC)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Brotman-Baty Institute for Precision Medicine, University of Minnesota, Seattle, WA, USA.

William B Dobyns (WB)

Division of Genetics and Metabolism, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.

Edward Novotny (E)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Division of Pediatric Neurology, Department of Neurology, Seattle Children's Hospital, Seattle, WA, USA.
Department of Neurology, University of Washington, Seattle, WA, USA.

Jason N N Wright (JNN)

Department of Radiology, Seattle Children's Hospital, Seattle, WA, USA.

Russell P Saneto (RP)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Division of Pediatric Neurology, Department of Neurology, Seattle Children's Hospital, Seattle, WA, USA.

Seth Friedman (S)

Center for Clinical and Translational Research, Seattle Children's Hospital, Seattle, WA, USA.

Jason Hauptman (J)

Department of Neurological Surgery, University of Washington, Seattle, WA, USA.

Jeffrey Ojemann (J)

Department of Neurological Surgery, University of Washington, Seattle, WA, USA.

Raj P Kapur (RP)

Department of Laboratories, Seattle Children's Hospital, Seattle, WA, USA.

Ghayda M Mirzaa (GM)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Brotman-Baty Institute for Precision Medicine, University of Minnesota, Seattle, WA, USA.
Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA.
Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH